These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29342259)

  • 1. False starts in 'test and start': a qualitative study of reasons for delayed antiretroviral therapy in Swaziland.
    Pell C; Vernooij E; Masilela N; Simelane N; Shabalala F; Reis R
    Int Health; 2018 Mar; 10(2):78-83. PubMed ID: 29342259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding reasons for discontinued antiretroviral treatment among clients in test and treat: a qualitative study in Swaziland.
    Shabalala FS; Vernooij E; Pell C; Simelane N; Masilela N; Spiegelman D; Chai B; Khan S; Reis R
    J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25120. PubMed ID: 30027651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Then her neighbour will not know her status': how health providers advocate antiretroviral therapy under universal test and treat.
    Pell C; Reis R; Dlamini N; Moyer E; Vernooij E
    Int Health; 2019 Jan; 11(1):36-41. PubMed ID: 30137387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of misdiagnosed HIV clients in an Early Access to ART for All implementation study in Swaziland.
    Khan S; Mafara E; Pasipamire M; Spiegelman D; Mazibuko S; Ntshalintshali N; Hettema A; Lejeune C; Walsh F; Okello V
    J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21756. PubMed ID: 28872273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deterrents to Immediate Antiretroviral Therapy Initiation by Pregnant Women Living with HIV in Hhohho Region, Swaziland.
    Mamba HT; Hlongwana KW
    Afr J Reprod Health; 2018 Dec; 22(4):72-80. PubMed ID: 30632724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peer-Delivered Linkage Case Management and Same-Day ART Initiation for Men and Young Persons with HIV Infection - Eswatini, 2015-2017.
    MacKellar D; Williams D; Bhembe B; Dlamini M; Byrd J; Dube L; Mazibuko S; Ao T; Pathmanathan I; Auld AF; Faura P; Lukhele N; Ryan C
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(23):663-667. PubMed ID: 29902168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'I need time to start antiretroviral therapy': understanding reasons for delayed ART initiation among people diagnosed with HIV in Lusaka, Zambia'.
    Mwamba C; Beres LK; Topp SM; Mukamba N; Simbeza S; Sikombe K; Mody A; Geng E; Holmes CB; Kennedy CE; Sikazwe I; Denison JA; Bolton Moore C
    Ann Med; 2022 Dec; 54(1):830-836. PubMed ID: 35311423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Life is so easy on ART, once you accept it": Acceptance, denial and linkage to HIV care in Shiselweni, Swaziland.
    Horter S; Thabede Z; Dlamini V; Bernays S; Stringer B; Mazibuko S; Dube L; Rusch B; Jobanputra K
    Soc Sci Med; 2017 Mar; 176():52-59. PubMed ID: 28129547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study.
    Musheke M; Bond V; Merten S
    AIDS Patient Care STDS; 2013 Apr; 27(4):231-41. PubMed ID: 23530573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of early initiation versus national standard of care of antiretroviral therapy in Swaziland's public sector health system: study protocol for a stepped-wedge randomized trial.
    Walsh FJ; Bärnighausen T; Delva W; Fleming Y; Khumalo G; Lejeune CL; Mazibuko S; Mlambo CK; Reis R; Spiegelman D; Zwane M; Okello V
    Trials; 2017 Aug; 18(1):383. PubMed ID: 28821264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I will take ARVs once my body deteriorates": an analysis of Swazi men's perceptions and acceptability of Test and Start.
    Adams AK; Zamberia AM
    Afr J AIDS Res; 2017 Dec; 16(4):295-303. PubMed ID: 29132279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to antiretroviral therapy initiation for HIV-positive children aged 2-18 months in Swaziland.
    Jolly P; Padilla LA; Ahmed C; Harris C; Mthethwa N; Jha M; Ba I; Styles A; Hope SP; Brooks R; Naluyinda-Kitabire F; Mamba M; Preko P
    Afr J AIDS Res; 2018 Jul; 17(2):193-202. PubMed ID: 30003844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Good health' as a barrier and facilitator to ART initiation: a qualitative study in the era of test-and-treat in Mozambique.
    Magaço A; Dovel K; Cataldo F; Nhassengo P; Hoffman R; Nerua L; Tique J; Saide M; Couto A; Mbofana F; Gudo E; Cuco RM; Chicumbe S
    Cult Health Sex; 2019 Sep; 21(9):1059-1073. PubMed ID: 30636559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
    Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
    AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-serostatus disclosure in the context of free antiretroviral therapy and socio-economic dependency: experiences among women living with HIV in Tanzania.
    Bohle LF; Dilger H; Groß U
    Afr J AIDS Res; 2014 Sep; 13(3):215-27. PubMed ID: 25388976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape.
    Fehr J; Nicca D; Goffard JC; Haerry D; Schlag M; Papastamopoulos V; Hoepelman A; Skoutelis A; Diazaraque R; Ledergerber B
    Infection; 2016 Aug; 44(4):521-9. PubMed ID: 26983974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study.
    Montalto GJ; Sawe FK; Miruka A; Maswai J; Kiptoo I; Aoko A; Oreyo C; Obiero E; Korir S; Bii SK; Song KX; Kunz AN
    PLoS One; 2017; 12(10):e0183180. PubMed ID: 28991913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative analysis of the barriers to antiretroviral therapy initiation among children 2 to 18 months of age in Swaziland.
    Ahmed CV; Jolly P; Padilla L; Malinga M; Harris C; Mthethwa N; Ba I; Styles A; Perry S; Brooks R; Naluyinda-Kitabire F; Mamba M; Preko P
    Afr J AIDS Res; 2017 Dec; 16(4):321-328. PubMed ID: 29132287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa.
    Cluver LD; Hodes RJ; Toska E; Kidia KK; Orkin FM; Sherr L; Meinck F
    AIDS; 2015 Jun; 29 Suppl 1():S57-65. PubMed ID: 26049539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.